SDC1 and plasma cell myeloma: The compound CQ-8 and the analogous HCQ derivative showed 70% killing of CD138+ myeloma cells, while a corresponding conjugate of bortezomib (a drug used to treat multiple myeloma) killed 65% of the cells.